Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3733074014 | Isradipine only product | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3733075010 | Product containing only isradipine (medicinal product) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 2866371000001111 | Isradipine (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
| 2866381000001113 | Isradipine | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Isradipine | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Isradipine | Has active ingredient | Isradipine | true | Inferred relationship | Existential restriction modifier | 1 | |
| Isradipine | Is a | Product containing isradipine | true | Inferred relationship | Existential restriction modifier | ||
| Isradipine | Is a | Virtual therapeutic moiety | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing only isradipine in oral dose form (medicinal product form) | Is a | True | Isradipine | Inferred relationship | Existential restriction modifier | |
| Product containing precisely isradipine 2.5 milligram/1 each conventional release oral tablet | Is a | True | Isradipine | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR